You are here: Home > Provider Resources > TRICARE Resources > Value Options
   


Toll Free: 1-800-700-8646

            
ValueOptions Home
           
 

Image of children

 

Substance Related Disorders

   


Substance Related Disorders

The disorders range from the taking of a drug of abuse (including alcohol), to the side effects of a medication, and to toxin exposure.  In the DSM-IV-TR the Substance-Related Disorders are divided into two groups:
  

A.  The Substance Use Disorders

  1. Substance Dependence
  2. Substance Abuse
B.  The Substance-Induced Disorders
  1. Substance Intoxication
  2. Substance Withdrawal
  3. Substance-Induced Delirium
  4. Substance-Induced Persisting Dementia
  5. Substance-Induced Persisting Amnesic Disorder
  6. Substance-Induced Psychotic Disorder
  7. Substance-Induced Mood Disorder
  8. Substance-Induced Anxiety Disorder
  9. Substance-Induced Sexual Dysfunction
  10. Substance-Induced Sleep Disorder

Back to Top

The Substance Use Disorder classified as Dependence can be applied to every class of substance except caffeine. Dependence is defined as a cluster of cognitive, behavioral, and physiological symptoms indicating the individual continues use of the substance despite significant substance related problems. There is a pattern of repeated self-administration that usually results in tolerance, withdrawal and compulsive drug taking behavior. Where as abuse is a maladaptive pattern of substance use manifested by recurrent and significant adverse consequences related to the repeated use of substances. These problems must occur recurrently during the same 12-month period (as does dependence). Unlike dependence, substance abuse criteria does not include tolerance, withdrawal, or a pattern of compulsive use.

 

The preceding has been a very brief summary of “Substance-Related Disorders.” Please refer to the DSM-IV-TR for the specific criteria for each disorder and the specifiers, or the following Internet resources:

Back to Top

 
Websites of interest:
 
Substance Abuse and Mental Health Services Administration
      
National Institute on Drug Abuse

 

      
American Psychiatric Association Clinical Practice Guidelines:


Back to Top

  
Author:Steven Batton, DO
Associate Medical Director-Value Options

Last Reviewed: April 24, 2008